A detailed history of North Star Asset Management Inc transactions in Ardelyx, Inc. stock. As of the latest transaction made, North Star Asset Management Inc holds 55,000 shares of ARDX stock, worth $273,350. This represents 0.02% of its overall portfolio holdings.

Number of Shares
55,000
Previous 55,000 -0.0%
Holding current value
$273,350
Previous $407,000 7.13%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$6.05 - $9.74 $6,050 - $9,740
-1,000 Reduced 1.79%
55,000 $401,000
Q4 2023

Feb 01, 2024

BUY
$3.29 - $6.64 $184,240 - $371,840
56,000 New
56,000 $347,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $769M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track North Star Asset Management Inc Portfolio

Follow North Star Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on North Star Asset Management Inc with notifications on news.